Thus, given our work suggests that targeting PrPC could be of benefit in several neurodegenerative diseases we recommend the exploration of PrPC as a therapy which could be particularly useful in individuals with evidence of mixed pathologies. This evidence concerns the gene PRNP and neurodegenerative disease.